Cargando…

Acute renal artery infarction secondary to dysfibrinogenemia

Renal infarction is a rare occurrence accounting for 0.007% of patients seen in the emergency department for renal insufficiency or hypertension. Dysfibrinogenemia is also rare, and the combination of renal artery infarct in the setting of congenital dysfibrinogenemia has not been described in the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Keinath, Kyle, Church, Tyler, Sadowski, Brett, Perkins, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695362/
https://www.ncbi.nlm.nih.gov/pubmed/29122898
http://dx.doi.org/10.1136/bcr-2017-221375
_version_ 1783280299189207040
author Keinath, Kyle
Church, Tyler
Sadowski, Brett
Perkins, Jeremy
author_facet Keinath, Kyle
Church, Tyler
Sadowski, Brett
Perkins, Jeremy
author_sort Keinath, Kyle
collection PubMed
description Renal infarction is a rare occurrence accounting for 0.007% of patients seen in the emergency department for renal insufficiency or hypertension. Dysfibrinogenemia is also rare, and the combination of renal artery infarct in the setting of congenital dysfibrinogenemia has not been described in the literature. Our patient, with a remote history of congenital dysfibrinogenemia with no known haemorrhagic or thrombotic complications, presented with acute flank pain and was subsequently diagnosed with an acute renal arterial infarction. He was treated with subcutaneous enoxaparin and then transitioned to lifelong anticoagulation with rivaroxaban therapy.
format Online
Article
Text
id pubmed-5695362
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56953622018-01-03 Acute renal artery infarction secondary to dysfibrinogenemia Keinath, Kyle Church, Tyler Sadowski, Brett Perkins, Jeremy BMJ Case Rep Rare Disease Renal infarction is a rare occurrence accounting for 0.007% of patients seen in the emergency department for renal insufficiency or hypertension. Dysfibrinogenemia is also rare, and the combination of renal artery infarct in the setting of congenital dysfibrinogenemia has not been described in the literature. Our patient, with a remote history of congenital dysfibrinogenemia with no known haemorrhagic or thrombotic complications, presented with acute flank pain and was subsequently diagnosed with an acute renal arterial infarction. He was treated with subcutaneous enoxaparin and then transitioned to lifelong anticoagulation with rivaroxaban therapy. BMJ Publishing Group 2017-11-08 /pmc/articles/PMC5695362/ /pubmed/29122898 http://dx.doi.org/10.1136/bcr-2017-221375 Text en © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Rare Disease
Keinath, Kyle
Church, Tyler
Sadowski, Brett
Perkins, Jeremy
Acute renal artery infarction secondary to dysfibrinogenemia
title Acute renal artery infarction secondary to dysfibrinogenemia
title_full Acute renal artery infarction secondary to dysfibrinogenemia
title_fullStr Acute renal artery infarction secondary to dysfibrinogenemia
title_full_unstemmed Acute renal artery infarction secondary to dysfibrinogenemia
title_short Acute renal artery infarction secondary to dysfibrinogenemia
title_sort acute renal artery infarction secondary to dysfibrinogenemia
topic Rare Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695362/
https://www.ncbi.nlm.nih.gov/pubmed/29122898
http://dx.doi.org/10.1136/bcr-2017-221375
work_keys_str_mv AT keinathkyle acuterenalarteryinfarctionsecondarytodysfibrinogenemia
AT churchtyler acuterenalarteryinfarctionsecondarytodysfibrinogenemia
AT sadowskibrett acuterenalarteryinfarctionsecondarytodysfibrinogenemia
AT perkinsjeremy acuterenalarteryinfarctionsecondarytodysfibrinogenemia